Trials / Completed
CompletedNCT02090764
Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With Impetigo
A Phase III 2 Arms, Multicenter, Randomised, Double-blind Study to Assess the Efficacy and Safety of Ozenoxacin 1% Cream Applied Twice Daily for 5 Days Versus Placebo in the Treatment of Patients With Impetigo
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 412 (actual)
- Sponsor
- Ferrer Internacional S.A. · Industry
- Sex
- All
- Age
- 2 Months
- Healthy volunteers
- Not accepted
Summary
This is multicenter, randomised, placebo controlled, parallel, double blinded , superiority clinical study comparing ozenoxacin cream versus placebo, in patients with a clinical diagnosis of non-bullous or bullous impetigo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ozenoxacin | |
| DRUG | Placebo |
Timeline
- Start date
- 2014-06-01
- Primary completion
- 2015-05-01
- Completion
- 2015-05-01
- First posted
- 2014-03-18
- Last updated
- 2024-08-20
- Results posted
- 2016-05-19
Locations
1 site across 1 country: Puerto Rico
Source: ClinicalTrials.gov record NCT02090764. Inclusion in this directory is not an endorsement.